CRISPR Babies & The Future of Human Genome Editing
Join National Academies’ project manager Anne-Marie Mazza on May 15th for the launch of the Spring 2019 Issues in Science and Technology.
Late last year, the Chinese scientist He Jiankui announced the birth of twin girls whose embryos he had genetically modified for HIV resistance using CRISPR, a powerful new gene editing technology. His announcement, at the Second International Summit on Human Genome Editing in Hong Kong, ignited a firestorm of debate over governance, ethics, and consensus in the scientific community and beyond.
The Spring 2019 Issues in Science and Technology features a special section of essays by luminaries in the field weighing in on this urgent and ongoing debate. To celebrate the issue’s publication, Anne-Marie Mazza, the primary coordinator of both the Hong Kong meeting where He spoke about his research and the 2015 human genome editing summit in Washington, will provide context on the current state of human genome editing discussions and explore what the future holds for regulation of this powerful technology.
Watch video of the event: